Regulations, Legislation & Enforcement

Getty Images / Jessica Hyde

“Our board sees wisdom in admitting as CRN members those CBD companies who are playing by [the] rules," says CRN president and CEO

CRN member companies now include CBD specialists

By Adi Menayang

Having some companies specializing in the still-not-legal dietary ingredient CBD join CRN will help the trade group as it looks to “help FDA, or Congress, craft those regulations,” said Andrew Shao, CRN’s senior vice president of scientific and regulatory...

Getty Images

Puerto Rico launches probe into dietary supplement regulations

By Hank Schultz

The Puerto Rican commonwealth legislature has launched an investigation into what authorities it has to govern the dietary supplement industry, and what federal structures are already in place that pertain to the category.

FDA photo

Cancer institute head named acting FDA chief

By Hank Schultz

Dr Ned Sharpless, MD, who is the current head of the National Cancer Institute, will be the interim head of the Food and Drug Administration when Dr Scott Gottlieb, MD, leaves next month.

Getty Images

FROM THE EDITOR'S DESK

Sloppy messaging on product performance misleads consumers

By FROM THE EDITOR'S DESK: Being honest about product performance

Transparency in the messaging around dietary supplements should include a level of honesty about claims made about product attributes.

Getty Images

MacKay leaves CRN for cannabis firm; Shao returns in interim role

By Hank Schultz

Andrew Shao, PhD, will replace Duffy MacKay, ND, as head of scientific and regulatory affairs at the Council for Responsible Nutrition in an interim role. MacKay is leaving the organization for a similar role at cannabis specialist CV Sciences.

FDA Commissioner Dr Scott Gottlieb, MD, testified before Congress on Wednesday.  Photo courtesy of FDA.

Gottlieb: FDA plans meeting in April on new CBD regulations

By Hank Schultz

FDA Commissioner Dr. Scott Gottlieb said the agency is planning a public meeting in April to initiate a rule making procedure on CBD. The goal is to create “an appropriately efficient and predictable regulatory framework for regulating CBD products,”...

Getty Images

From the editor's desk

What should DSHEA 2.0 look like? Here are a couple of suggestions

By Hank Schultz

On Monday FDA Commissioner Scott Gottlieb put forward some ideas about where the regulation of dietary supplements should go in the coming years. This is an opportunity that should not be missed. What should be tops on the industry’s wish list?

Follow us

Products

View more

Webinars